Ascendis Pharma Expands TransCon™ PTH Phase 2 PaTH Forward Clinical Trial to Expedite Enrollment of Subjects Previously Treated with NATPARA® in the United States

    NEXT STORY
    CorMedix Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update
    PREV STORY
    Global Endoscope Market is Set to Reach USD 32.8 billion by 2024, Observing a CAGR of 7.5% during 2019–2024: VynZ Research
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Algernon Pharmaceuticals Appoints Leading Respirologist Dr. Martin Kolb to Its Medical and Scientific Advisory Board

    author_avatar
    NASDAQ Market News

    NeuBase Therapeutics Announces Addition of Industry Pioneer Dr. Samuel Broder and World-Renowned Geneticist Dr. George Church to Scientific Advisory Board

    author_avatar
    NASDAQ Market News

    Cortisone Market To Reach USD 1.54 Billion By 2026 | Reports And Data

    author_avatar
    NASDAQ Market News